EUVIMEDEUVIMED entdecken
Crossref

Intracellular Glucose‐Depriving Polymer Micelles for Antiglycolytic Cancer Treatment

Jangwook Lee iD, Kwangmeyung Kim, Ick Chan Kwon, Kuen Yong Lee iD

Advanced Materials · 2023

DOI: 10.1002/adma.202207342 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Materials, 2023. Verfasst von Jangwook Lee und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Bioengineering and Institute of Nano Science and Technology, Hanyang University, Seoul, 04763, Republic of Korea. Hauptthemen laut MEDLINE: Neoplasms, Antineoplastic Agents. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 55 Literaturangaben. Gefördert von: National Research Foundation of Korea (NRF) grant funded by the Korean government (MSIT), Korea Research Institute of Bioscience and Biotechnology (KRIBB) Research Initiative Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A new anticancer strategy to exploit abnormal metabolism of cancer cells rather than to merely control the drug release or rearrange the tumor microenvironment is reported. An antiglycolytic amphiphilic polymer, designed considering the unique metabolism of cancer cells (Warburg effect) and aimed at the regulation of glucose metabolism, is synthesized through chemical conjugation between glycol chitosan (GC) and phenylboronic acid (PBA). GC‐PBA derivatives form stable micellar structures under physiological conditions and respond to changes in glucose concentration. Once the micelles accumulate at the tumor site, intracellular glucose capture occurs, and the resultant energy deprivation through the inhibition of aerobic glycolysis remarkably suppresses tumor growth without significant side effects in vivo. This strategy highlights the need to develop safe and effective cancer treatment without the use of conventional anticancer drugs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeoplasmsAntineoplastic AgentsHumansMicellesPolymersGlucoseDrug LiberationDrug CarriersTumor Microenvironment

Stichwörter der Autor:innen

apoptosiscancer therapyglucose-responsive polymersinduced energy deficiencynutrient deprivation

Substanzen

MicellesPolymersGlucoseDrug CarriersAntineoplastic Agents

Autor:innen und Institutionen

  • Department of Bioengineering and Institute of Nano Science and Technology, Hanyang University, Seoul, 04763, Republic of Korea.
  • Biotherapeutics Translational Research Center, Korea Research Institute of Bioscience and Biotechnology, Daejeon, 34141, Republic of Korea.
  • Department of Biomolecular Science, KRIBB School of Bioscience, Korea University of Science and Technology, Daejeon, 34113, Republic of Korea.
  • College of Pharmacy, Graduate School of Pharmaceutical Sciences, Ewha Womans University, Seoul, 03760, Republic of Korea.
  • Medicinal Materials Research Center, Biomedical Research Division, Korea Institute of Science and Technology, Seoul, 02792, Republic of Korea.
  • KU-KIST Graduate School of Converging Science and Technology, Korea University, Seoul, 02841, Republic of Korea.

ORCID-Profile: Jangwook Lee, Kuen Yong Lee

Förderung

  • National Research Foundation of Korea (NRF) grant funded by the Korean government (MSIT)
  • Korea Research Institute of Bioscience and Biotechnology (KRIBB) Research Initiative Program

Zitieren

APA

Lee, J., Kim, K., Kwon, I. C., & Lee, K. Y. (2023). Intracellular Glucose‐Depriving Polymer Micelles for Antiglycolytic Cancer Treatment. Advanced Materials. https://doi.org/10.1002/adma.202207342

Vancouver

Lee J, Kim K, Kwon IC, Lee KY. Intracellular Glucose‐Depriving Polymer Micelles for Antiglycolytic Cancer Treatment. Advanced Materials. 2023. doi:10.1002/adma.202207342

BibTeX
@article{Lee2023,
  author = {Lee, Jangwook and Kim, Kwangmeyung and Kwon, Ick Chan and Lee, Kuen Yong},
  title = {Intracellular Glucose‐Depriving Polymer Micelles for Antiglycolytic Cancer Treatment},
  journal = {Advanced Materials},
  year = {2023},
  doi = {10.1002/adma.202207342}
}
Kostenlos starten →